Sparreboom, Alex

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab -Paclitaxel

Gardner, E. R., Dahut, W. L., Scripture, C. D., Jones, J., Aragon-Ching, J. B., Desai, N., Hawkins, M. J., Sparreboom, A., & Figg, W. D. (2008) · Clinical Cancer Research

Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery

Cited by 226

Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia.

van der Bol, J. M., Mathijssen, R. H. J., Loos, W. J., Friberg, L. E., van Schaik, R. H. N., de Jonge, M. J. A., Planting, A. S. T., Verweij, J., Sparreboom, A., & de Jong, F. A. (2007) · Journal of Clinical Oncology

Pharmacogenetics and Drug MetabolismCancer therapeutics and mechanisms

Cited by 128

Measurement of Fraction Unbound Paclitaxel in Human Plasma

Brouwer, E., Verweij, J., De Bruijn, P., Loos, W. J., Pillay, M., Buijs, D., & Sparreboom, A. (2000) · Drug Metabolism and Disposition

Cancer Treatment and PharmacologyDrug Transport and Resistance Mechanisms

Cited by 98

Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood–Brain Barrier in Glioblastoma Patients Using an IVIVE–PBPK Modeling Approach

Li, J., Wu, J., Bao, X., Honea, N., Xie, Y., Kim, S., Sparreboom, A., & Sanai, N. (2017) · Clinical Cancer Research

Drug Transport and Resistance MechanismsBarrier Structure and Function Studies

Cited by 68